Clinical Trial on the Visual Function of Enhanced Monofocal and EDoF Intraocular Lenses

Randomized Clinical Trial to Evaluate the Visual Function of Enhanced Monofocal and Extended Depth of Field Intraocular Lenses

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07715071

Enrollment

Registered

2026-07-20

Start date

2026-09-21

Completion date

2027-03-31

Last updated

2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Intraocular lens, Cataract, Enhanced monfocoal IOL, EDoF IOL

Brief summary

Randomized clinical trial to evaluate the visual performance of enhanced monofocal and extended depth-of-field intraocular lenses

Detailed description

Primary Objective To evaluate whether the implantation of enhanced monofocal intraocular lenses during cataract surgery results in fewer adverse visual phenomena (dysphotopsias) than the implantation of extended depth-of-field (EDoF) intraocular lenses. Secondary Objectives To evaluate whether there are differences in best-corrected visual acuity at various distances, contrast sensitivity, visual quality, and quality of life between patients implanted with enhanced monofocal intraocular lenses and those implanted with extended depth-of-field intraocular lenses. To evaluate whether there are differences in best-corrected visual acuity at various distances, contrast sensitivity, visual quality, and quality of life among the four enhanced monofocal intraocular lenses analyzed in the present study. To evaluate whether there are differences in best-corrected visual acuity at various distances, contrast sensitivity, visual quality, and quality of life between the two extended depth-of-field intraocular lenses analyzed in the present study.

Interventions

DEVICEIntraocular lens

Implantation of intraocular lens

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

45 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients with bilateral cataracts at different stages of development. * Patients with functional visual demands. * Age between 45 and 80 years. * Male or female sex. * Ability to provide informed consent.

Exclusion criteria

Preoperative

Design outcomes

Primary

Measure	Time frame	Description
Visual acuity at different distances	1 month, 3 months, 6 months	Far vision, intermediate vision, near vision
Dysphotopsias	1 month, 3 months, 6 months	Dysphotopsias after the IOL implantation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026